51
Participants
Start Date
December 19, 2023
Primary Completion Date
September 30, 2027
Study Completion Date
January 31, 2028
VB10.16
"Intramuscular (i.m.) administrations of VB10.16 every 3 weeks (Q3W) starting at Week 1/Day 1 during a 12-week induction period, followed by a maintenance period with administrations every 6 weeks (Q6W) from Week 13 until Week 48. A total of up to 10 i.m. administrations will be given.~VB10.16 will be administered via Pharma Jet® Stratis 0.5 mL needle free injection system."
Pembrolizumab
"Pembrolizumab 200 mg intravenous (i.v.) will be given in accordance with the local regulatory-approved label Q3W starting at Week 1/Day 1 for as long as the patient tolerates and continues to have clinical benefit from the treatment based on the patient and investigator's decision, up to a maximum of 35 treatments corresponding to approximately 2 years of treatment.~After 48 weeks of treatment patients can continue on 200 mg Q3W or change to 400 mg Q6W at the discretion of the investigator and after consultation with the sponsor.~Pembrolizumab will be given by i.v. infusion over 30 minutes."
RECRUITING
CRLC Val d'Aurelle - Institut de Recherche en Cancerologie de Montpellier (IRCM), Montpellier
RECRUITING
Hôpital de la Pitié - Salpétrière in Paris, Paris
RECRUITING
Fakultni nemocnice Olomouc, Olomuoc, Olomouc
RECRUITING
Hospices Civils De Lyon, Lyon
RECRUITING
Institut Gustave Roussy, Paris, Paris
RECRUITING
Universität Leipzig Klinik und Poliklinik für Hals-, Nasen-, Ohrenheilkunde, Leipzig
RECRUITING
Orszagos Onkologiai Intezet, Budapest, Budapest
RECRUITING
University of Bergen, Haukeland University Hospital, Bergen
RECRUITING
Oslo Universitetssykehus, Oslo
RECRUITING
Uniwersyteckie Cetrum Kliniczne, Gdansk
RECRUITING
Narodowy Instytut Onkologii-im Marii Sklodowskiej-Curie Panstwowy Instytut, Gliwice
RECRUITING
KO-MED Centra Kliniczne Lublin II, Lublin, Lublin
RECRUITING
Hospital del Mar, Barcelona, Barcelona
RECRUITING
Institut Catala d'Oncologia, Barcelona, Barcelona
RECRUITING
Hospital Universitario Virgen de las Nieves, Granada, Granada
RECRUITING
MD Anderson Cancer Center, Madrid, Madrid
RECRUITING
East and North Hertfordshire NHS Trust Mount Vernon Hospital, London
Lead Sponsor
Merck Sharp & Dohme LLC
INDUSTRY
Nykode Therapeutics ASA
INDUSTRY